MediPharm Labs Corp. (LABS.TO) TSX
0.08
+0.005(+6.67%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 27.35M |
| Enterprise Value | 16.74M |
| P/E Ratio | -3.89 |
| PEG Ratio | -2.55 |
| Price/Sales Ratio | 0.79 |
| Price/Book Ratio | 0.97 |
| Enterprise/Revenue | 0.56 |
| Enterprise/EBITDA | -3.42 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.2 |
| Operating Margin | -0.2 |
Management Effectiveness
| Return On Assets | -0.2 |
| Return On Equity | -0.24 |
Income Statement
| Revenue | 45.12M |
| Revenue/Share | 0.1 |
| Gross Profit | 13.97M |
| EBITDA | -6.54M |
| Net Income | -8.27M |
| Diluted EPS | -0.02 |
Balance Sheet
| Total Cash | 9.87M |
| Total Cash/Share | 0.02 |
| Total Debt | 18,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.02 |
| Book Value Per Share | 0.08 |
Price History
| 52-Week Change | 6.67 |
| 52-Week High | 0.1 |
| 52-Week Low | 0.06 |
| Moving Average 50 Days | 0.07 |
| Moving Average 200 Days | 0.07 |
Statistics
| Average Volume | 301,342 |
| Shares Outstanding | 424.86M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | October 04, 2018 |
